In January 2026, Medtronic announced FDA clearance for its MiniMed Go™ Smart MDI System, a connected solution designed for insulin-dependent patients who use multiple daily injections.
While insulin pumps often dominate diabetes technology discussions, the majority of patients still rely on injections. This approval signals a shift toward smarter tools for the MDI population.
Why This Matters
- MDI patients historically lack decision-support tools
- Connected data reduces missed doses and guesswork
- Software-driven care is becoming standard in medical devices
This FDA clearance represents more than a device launch — it reflects where connected care is heading.
Explore Medical Sales Jobs